Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) — Capital Reinvestment Ratio

Latest as of March 2025: 5.82x

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a Capital Reinvestment Ratio of 5.82x as of March 2025, meaning it reinvests 6% of its operating cash flow (Rs8.95 Million) in capital expenditures (Rs52.04 Million). See net asset quality index of Aarey Drugs & Pharmaceuticals Limited to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

5.82x
Capex / Operating Cash Flow

Operating Cash Flow

Rs8.95 Million
INR

Capital Expenditures

Rs52.04 Million
INR

Data as of

Mar 2025
Most recent filing

Aarey Drugs & Pharmaceuticals Limited Capital Reinvestment Ratio (2009–2025)

This chart tracks Aarey Drugs & Pharmaceuticals Limited's Capital Reinvestment Ratio across 9 annual periods. Check AAREYDRUGS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Aarey Drugs & Pharmaceuticals Limited (2009–2025)

Year-by-year Capital Reinvestment Ratio for Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025. For live market cap and broader valuation context, see Aarey Drugs & Pharmaceuticals Limited stock valuation.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2025 5.82x Rs8.95 Million Rs52.04 Million ▲ +1006.4%
2021 0.53x Rs54.77 Million Rs28.79 Million ▲ +63.5%
2020 0.32x Rs28.57 Million Rs9.19 Million ▼ -82.0%
2019 1.78x Rs6.89 Million Rs12.28 Million ▼ -65.2%
2017 5.13x Rs9.62 Million Rs49.35 Million ▲ +1025.9%
2016 0.46x Rs56.59 Million Rs25.78 Million ▼ -39.0%
2015 0.75x Rs32.53 Million Rs24.31 Million ▲ +1423.2%
2013 0.05x Rs33.72 Million Rs1.65 Million ▼ -99.7%
2009 18.99x Rs302.06K Rs5.73 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow